In a recent observational study published in the journal Immunity, researchers from the United States of America investigated the longevity of antibody responses to severe acute respiratory syndrome ...
In a recent research paper uploaded to the bioRxiv preprint* server, researchers developed and tested novel bispecific antibodies (bsAbs) comprising both the N-terminal domain (NTD) and the receptor ...
How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...
Human neutralizing antibodies against SARS-CoV-2 are isolated from the convalescent patient. A high affinity monoclonal antibody mAb-39 neutralizes SARS-CoV-2 original strain and Omicron variants, as ...
A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...
In summer 2025, the SARS-CoV-2 JN.1 sublineage became dominant with more resistant variants, such as XFG, LP.8.1, and NB.1.8.1. COVID-19 mRNA boosters were therefore updated for the 2025–2026 season ...
A long-term analysis reveals that antibody responses induced by COVID-19 vaccines are long-lasting. The study results challenge the idea that mRNA-based vaccine immunity wanes quickly. A long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results